BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drozdzik M, Czekawy I, Oswald S, Drozdzik A. Intestinal drug transporters in pathological states: an overview. Pharmacol Rep 2020;72:1173-94. [PMID: 32715435 DOI: 10.1007/s43440-020-00139-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pangeni R, Kang S, Jha SK, Subedi L, Park JW. Intestinal membrane transporter-mediated approaches to improve oral drug delivery. J Pharm Investig 2021;51:137-58. [DOI: 10.1007/s40005-021-00515-1] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Petryszyn P, Dudkowiak R, Gruca A, Jaźwińska-Tarnawska E, Ekk-Cierniakowski P, Poniewierka E, Wiela-Hojeńska A, Głowacka K. C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case-Control and Meta-Analysis Study. Genes (Basel) 2021;12:1419. [PMID: 34573401 DOI: 10.3390/genes12091419] [Reference Citation Analysis]
3 Li J, Zhang Y, Yu M, Wang A, Qiu Y, Fan W, Hovgaard L, Yang M, Li Y, Wang R, Li X, Gan Y. The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery. Acta Pharm Sin B 2022;12:1460-72. [PMID: 35530154 DOI: 10.1016/j.apsb.2021.07.024] [Reference Citation Analysis]
4 Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J, Rollason V. Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. JPM 2022;12:526. [DOI: 10.3390/jpm12040526] [Reference Citation Analysis]
5 Wang Y, Qin L, Chen W, Chen Q, Sun J, Wang G. Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1. Eur J Med Chem 2021;226:113806. [PMID: 34517305 DOI: 10.1016/j.ejmech.2021.113806] [Reference Citation Analysis]
6 Droździk M, Oswald S, Droździk A. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract. Int J Mol Sci 2020;21:E5737. [PMID: 32785140 DOI: 10.3390/ijms21165737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ashkar A, Sosnik A, Davidovich-Pinhas M. Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv 2021;:107789. [PMID: 34186162 DOI: 10.1016/j.biotechadv.2021.107789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Liao S, Luo J, Kadier T, Ding K, Chen R, Meng Q. Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury. Front Pharmacol 2022;13:854994. [PMID: 35370747 DOI: 10.3389/fphar.2022.854994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 He Y, He G, He T. Specifically Targeted Transport of Plasma Membrane Transporters: From Potential Mechanisms for Regulating Cell Health or Disease to Applications. Membranes (Basel) 2021;11:736. [PMID: 34677502 DOI: 10.3390/membranes11100736] [Reference Citation Analysis]
10 Arian CM, Imaoka T, Yang J, Kelly EJ, Thummel KE. Gutsy science: In vitro systems of the human intestine to model oral drug disposition. Pharmacol Ther 2021;:107962. [PMID: 34478775 DOI: 10.1016/j.pharmthera.2021.107962] [Reference Citation Analysis]
11 Torres AM, Dnyanmote AV, Granados JC, Nigam SK. Renal and non-renal response of ABC and SLC transporters in chronic kidney disease. Expert Opin Drug Metab Toxicol 2021;17:515-42. [PMID: 33749483 DOI: 10.1080/17425255.2021.1899159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]